Grants for County governments - Health

The Air Products Greater Massena Community Fund, administered by the Northern New York Community Foundation, offers financial assistance to qualified 501(c)(3) organizations and local governing bodies. Its primary mission is to enhance the quality of life for residents within the Greater Massena community. This aligns with the foundation's broader goal of supporting community needs, as evidenced by its commitment to programs that benefit areas such as health and wellness, arts and culture, human services, education, families, youth and/or elders, environment and conservation, community development, and recreation. The target beneficiaries of this grant program are residents of the Greater Massena community, particularly those in disadvantaged communities within St. Lawrence and Franklin Counties. The impact goal is to improve various aspects of community life through diverse programs and initiatives. While specific measurable results are not explicitly detailed for each category, the evaluation process emphasizes the potential impact on the Massena community, especially its support for disadvantaged populations. The grant program's priorities and focuses are broad, encompassing a wide array of community needs. These include, but are not limited to, health and wellness, arts and culture, human services, education, families, youth and/or elders, environment and conservation, community development, and recreation. Each grant request undergoes an evaluation based on its potential impact, the amount of available funding, and the quality of the applicant's planning, leadership, and proposal support. The foundation's strategic priorities and theory of change are centered on fostering positive community development and improving the quality of life through targeted financial support. By providing grants ranging from $1,000 to $10,000, with an upper limit of $7,500 per application, the fund aims to empower local organizations and governing bodies to address pressing community needs. The deadline for applications is July 31, 2024, indicating a structured approach to funding cycles. More information can be found by visiting the Northern New York Community Foundation.

The "Neuropathological Interactions Between COVID-19 and ADRD" grant aims to fund research that investigates how COVID-19 affects the brain and cognitive outcomes in models with Alzheimer's Disease and related dementias (AD/ADRD), how it accelerates these conditions in early stages, and how it potentially increases the risk for future AD/ADRD.

This funding opportunity provides financial support to state and tribal governments to improve mental health services for children and youth with serious emotional disturbances and their families.

This funding provides up to $3.3 billion to cities, counties, and tribal entities in California to develop and improve facilities that expand behavioral health treatment and services for Medi-Cal beneficiaries.

The Shullsburg Fund, established in 2004 by area citizens, serves as a permanent funding source dedicated to enhancing the quality of life in and around Shullsburg. Managed as a component of the Community Foundation of Southern Wisconsin, it annually redistributes a portion of its earnings to finance projects and programs that positively impact community life. The fund focuses on supporting non-profit organizations, the local school district, and local government agencies with charitable initiatives. Grants are ceremoniously awarded in June each year, underlining the fund's commitment to community development and welfare. Grant renewed every year. Grant annual deadline: May 15th

The purpose of this funding opportunity is to support the development of Clinical Outcome Assessments (COA) for Substance Use Disorders (SUD). The COA development plan is expected to progress into the FDA drug development tool qualification program. This notice of funding opportunity (NOFO) utilizes the UG3/UH3Phased Innovation Awards Cooperative Agreement grant mechanism that includes two phases. The applications responding to this NOFO should contain a COA development plan that will cover both UG3 and UH3 phases. In the first 2-year UG3 phasethe project must have a set of operational milestones to be completed by the end of this period. Once NIDA program has evaluated the progress of the UG3 phase and determined that the UG3 phase has been successfully completed, it transitions to the UH3 phase to be funded for three additional years.The goal of this NOFO is to expand the armamentarium of COA that are FDA qualified as drug development tool (DDT) in the context of use (COI) of a SUD. Achieving this goal will greatly facilitate the development of treatments for SUDs. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

This funding opportunity supports research institutions and organizations in developing innovative technologies to study how neural cell groups in rodents respond to addictive substances, aiming to deepen our understanding of addiction-related behaviors.

This funding opportunity provides financial support to state and local governments, community organizations, and other eligible entities to improve access to long-term services and supports by enhancing their No Wrong Door systems through collaboration and modernization efforts.

This funding opportunity supports innovative research on new screening methods and treatments for severe conditions detectable in newborns, aimed at improving early detection and health outcomes.

This grant provides funding for institutional research training programs to develop skilled neuroscientists through comprehensive training in research, statistics, and communication, specifically targeting advanced graduate students and postdoctoral fellows.

This funding opportunity supports researchers in developing innovative theories and methods to better understand the complex interactions of genetic and non-genetic factors influencing human traits, particularly in relation to health and cancer risk.

The grant titled "Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Data Coordinating Center (Collaborative U24 Trial Required)" is aimed at funding the development and implementation of a Data Coordinating Center to manage data, provide statistical support, and ensure overall coordination for a multi-site clinical trial focused on preventing cardiovascular disease in young adults at high risk, while also promoting community engagement, diversity, and health equity.

On November 6, 2018, California voters passed Proposition 4, the Children's Hospital Bond Act of 2018. The purpose of the program is to improve the health and welfare of California’s critically ill children, by providing a stable and ready source of funds for capital improvement projects for eligible hospitals. The California Health Facilities Financing Authority (CHFFA) is responsible for administering the program. Language in Proposition 4 identifies 13 children’s hospitals in California (referred to as “Children’s Hospitals”) as eligible for $1.35 billion in funding. The 13 Children's Hospitals designated by statute are the same as the 13 hospitals that received grants under the first two Children’s Hospital Programs also administered by CHFFA and enacted by Proposition 61 in 2004 and Proposition 3 in 2008. The 13 Children’s Hospitals consist of eight private nonprofit Children’s Hospitals and five University of California Children’s Hospitals. Grant awards for each private nonprofit Children’s Hospital was limited to $135 million, less costs of issuance and administrative costs. Grant awards for each University of California Children’s Hospital was limited to $54 million, less costs of issuance and administrative costs. Costs of issuance are $0.75 per $1,000 of the authorized grant award and administrative costs are $10.00 per $1,000 of the authorized grant award. Applications are accepted on an ongoing basis until June 30, 2033 and are due the first business day of each month, except October and November, and will be presented to the Authority the following month. For the month of October, Applications are due on October 7. Applications received on October 7 will be presented for Authority consideration at a regularly scheduled meeting in December or January. Applications are not accepted in November. Applications shall be submitted in duplicate to the Authority. Each Children’s Hospital may apply more than once. Submit completed Application by mail or in-person to: California Health Facilities Financing Authority Children’s Hospital Program 901 P Street Room 313 Sacramento, CA 95814

The "Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults" grant aims to fund a network of clinical trials that will study the safety and potential effectiveness of psychedelic drugs in treating chronic pain in older adults, with a focus on those aged 75 and above.

This funding opportunity supports innovative research teams using non-human animal models to develop advanced methods for measuring and analyzing behavior in relation to environmental factors.

HIV infection and substance use are comorbid conditions that bidirectionally and synergistically influence the deleterious outcomes in people who suffer from substance use disorders (SUD). The persistence and transcriptional reactivation of HIV lead to the development of neuropathological complications. Strategies to address viral latency include silencing of HIV transcription and reactivation and clearance. The goal of this initiative is to support research aimed at (1) identification of targets and pathways by which transcriptional activity of HIV can be suppressed in HIV reservoirs including the CNS in people with SUD, and (2) application of emerging small molecule drug discovery approaches to identify novel compounds that can be utilized as pharmacological probes and as drugs to suppress HIV transcription in people with HIV-SUD comorbidity.

This funding opportunity provides financial support to rural libraries in Oregon to create community-focused humanities events that explore themes related to public life and community engagement.

This grant provides funding to national organizations focused on improving lupus awareness, diagnosis, treatment, and self-management among affected populations, particularly women aged 15 to 44.

This fellowship provides unrestricted financial support to artists living in the Southern Finger Lakes region, allowing them to focus on their creative work without project constraints.

This funding opportunity provides financial support to nonprofit organizations and educational institutions to implement and evaluate anti-stigma interventions that improve access to HIV care and prevention services across the U.S.